(INNS)
TIMOLUMAB(SLE)
TIMOLUMAB(INNC)
IMMUNOGLOBULIN G4-KAPPA, ANTI-[HOMO SAPIENS AOC3 (AMINE OXIDASE COPPER CONTAINING 3 (EC1.4.3.21), VASCULAR ADHESION PROTEIN 1, VAP1, VAP-1)], HOMO SAPIENS MONOCLONAL ANTIBODY; GAMMA4 HEAVY CHAIN (1-444) [HOMO SAPIENS VH (IGHV3- 30*01 (91.80%) -(IGHD) -IGHJ4*01) [8.8.10] (1-117) - IGHG4*01 (CH1 (118-215), HINGE S10>P (225) (216-227), CH2 L1.2>A (232) (228-337), CH3 (338-442), CHS (443- 444)) (118-444)], (131-214')-DISULFIDE WITH KAPPA LIGHT CHAIN (1'-214') [HOMO SAPIENS (V-KAPPA (IGKV1-13*02 (97.90%) -IGKJ4*01) [6.3.9] (1'-107') -IGKC*01, KM3 (108'- 214')]; DIMER (223-223":226-226")-BISDISULFIDE, RECOMMENDED INN: LIST 76(WHO)
TIMOLUMABUM(INN)